Surfactant replacement therapy for preterm and term neonates with respiratory distress

Pediatrics

Volumn 133, Issue 1, 2014, Pages 156-163

  Polin, Richard A ^a   Carlo, Waldemar A ^a   Papile, Lu Ann ^a   Tan, Rosemarie ^a   Kumar, Praveen ^a   Benitz, William ^a   Eichenwald, Eric ^a   Cummings, James ^a   Baley, Jill ^a  

^a NONE

Author keywords

Antenatal steroids; Congenital diaphragmatic hernia; Meconium aspiration syndrome; Neonatal pneumonia; Neonatal sepsis; Persistent pulmonary hypertension; Preterm; Pulmonary hemorrhage; Respiratory distress syndrome; Surfactant; Term

Indexed keywords

BERACTANT; CALFACTANT; DIPALMITOYLPHOSPHATIDYLCHOLINE; LUCINACTANT; LUNG SURFACTANT; PORACTANT; STEROID;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG INDICATION; DRUG POTENTIATION; EARLY INTERVENTION; EXTUBATION; HUMAN; MECONIUM ASPIRATION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN SEPSIS; NONHUMAN; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; SUBSTITUTION THERAPY; THERAPY DELAY; TREATMENT OUTCOME;

EID: 84891795491     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-3443     Document Type: Article

References (58)

1. Engle WA; American Academy of Pediatrics Committee on Fetus and Newborn. Surfactantreplacement therapy for respiratory distress in the preterm and term neonate. Pediatrics. 2008;121(2): 419-432
2. Soll RF. Synthetic surfactant for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2000;(2):CD001149
3. Seger N, Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev. 2009; (2):CD007836
4. Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2001;(2):CD000144
5. Rojas-Reyes MX, Morley CJ, Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2012;3(3):CD000510
6. Stevens TP, Harrington EW, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev. 2007;(4):CD003063
7. Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2012;11(11):CD001456
8. Soll R, Ozek E. Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2010;(1): CD001079
9. Pfister RH, Soll R, Wiswell TE. Proteincontaining synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. Cochrane Database Syst Rev. 2009;(4):CD006180
10. Soll R, Ozek E. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2009;(1):CD000141
11. Soll RF. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2000;(2):CD000511
12. Suresh GK, Soll RF. Overview of surfactant replacement trials. J Perinatol. 2005;25 (suppl 2):S40-S44
13. Philip AG. Neonatal mortality rate: is further improvement possible? J Pediatr. 1995;126(3): 427-433
14. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2001;(2): CD000510
15. Dunn MS, Kaempf J, de Klerk A, et al Vermont Oxford Network DRM Study Group. Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics. 2011;128(5). Available at: www.pediatrics.org/cgi/content/full/128/5/e1069
16. Escobedo MB, Gunkel JH, Kennedy KA, et al Texas Neonatal Research Group. Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial. J Pediatr. 2004;144(6): 804-808
17. Moya F, Javier MC. Myth: all surfactants are alike. Semin Fetal Neonatal Med. 2011;16 (5): 269-274
18. Sinha SK, Lacaze-Masmonteil T, Valls i Soler A, et al Surfaxin Therapy Against Respiratory Distress Syndrome Collaborative Group. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics. 2005;115(4): 1030-1038
19. Moya F, Sinha S, Gadzinowski J, et al SELECT and STAR Study Investigators. Oneyear follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials. Pediatrics. 2007;119(6). Available at: www.pediatrics.org/cgi/content/full/119/6/e1361
20. Cogo PE, Facco M, Simonato M, et al. Pharmacokinetics and clinical predictors of surfactant redosing in respiratory distress syndrome. Intensive Care Med. 2011; 37(3): 510-517
21. Kendig JW, Ryan RM, Sinkin RA, et al. Comparison of two strategies for surfactant prophylaxis in very premature infants: a multicenter randomized trial. Pediatrics. 1998;101(6): 1006-1012
22. Ueda T, Ikegami M, Rider ED, Jobe AH. Distribution of surfactant and ventilation in surfactant-treated preterm lambs. J Appl Physiol (1985). 1994;76(1): 45-55
23. Zola EM, Gunkel JH, Chan RK, et al. Comparison of three dosing procedures for administration of bovine surfactant to neonates with respiratory distress syndrome. J Pediatr. 1993;122(3): 453-459
24. Valls-i-Soler A, López-Heredia J, Fernández- Ruanova MB, Gastiasoro E; Spanish Surfactant Collaborative Group. A simplified surfactant dosing procedure in respiratory distress syndrome: the "side-hole" randomized study. Acta Paediatr. 1997;86(7): 747-751
25. Göpel W, Kribs A, Ziegler A, et al German Neonatal Network. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet. 2011;378(9803): 1627-1634
26. Schmölzer GM, Agarwal M, Kamlin CO, Davis PG. Supraglottic airway devices during neonatal resuscitation: an historical perspective, systematic review and meta-analysis of available clinical trials. Resuscitation. 2013;84(6): 722-730
27. Kribs A. How best to administer surfactant to VLBW infants? Arch Dis Child Fetal Neonatal Ed. 2011;96(4):F238-F240
28. Mehler K, Grimme J, Abele J, Huenseler C, Roth B, Kribs A. Outcome of extremely low gestational age newborns after introduction of a revised protocol to assist preterm infants in their transition to extrauterine life. Acta Paediatr. 2012;101(12): 1232-1239
29. Abdel-Latif ME, Osborn DA. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome. Cochrane Database Syst Rev. 2011;(7):CD008309
30. Abdel-Latif ME, Osborn DA. Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome. Cochrane Database Syst Rev. 2012;(10):CD008310
31. Abdel-Latif ME, Osborn DA. Pharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndrome. Cochrane Database Syst Rev. 2011;(3):CD008311
32. Abdel-Latif ME, Osborn DA, Challis D. Intraamniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newborns. Cochrane Database Syst Rev. 2010;(1):CD007916
33. Finer NN. Surfactant use for neonatal lung injury: beyond respiratory distress syndrome. Paediatr Respir Rev. 2004;5(suppl A):S289-S297
34. Donn SM, Dalton J. Surfactant replacement therapy in the neonate: beyond respiratory distress syndrome. Respir Care. 2009;54(9): 1203-1208
35. El Shahed AI, Dargaville P, Ohlsson A, Soll RF. Surfactant for meconium aspiration syndrome in full term/near term infants. Cochrane Database Syst Rev. 2007;(3): CD002054
36. Lotze A, Knight GR, Martin GR, et al. Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation. J Pediatr. 1993;122(2): 261-268
37. Tan K, Lai NM, Sharma A. Surfactant for bacterial pneumonia in late preterm and term infants. Cochrane Database Syst Rev. 2012;(2):CD008155
38. Vento GM, Tana M, Tirone C, et al. Effectiveness of treatment with surfactant in premature infants with respiratory failure and pulmonary infection. Acta Biomed. 2012;83(suppl 1): 33-36
39. Aziz A, Ohlsson A. Surfactant for pulmonary haemorrhage in neonates. Cochrane Database Syst Rev. 2012;(7):CD005254
40. Cogo PE, Zimmermann LJ, Meneghini L, et al. Pulmonary surfactant disaturatedphosphatidylcholine (DSPC) turnover and pool size in newborn infants with congenital diaphragmatic hernia (CDH). Pediatr Res. 2003;54(5): 653-658
41. Van Meurs K; Congenital Diaphragmatic Hernia Study Group. Is surfactant therapy beneficial in the treatment of the term newborn infant with congenital diaphragmatic hernia? J Pediatr. 2004;145(3): 312-316
42. Lally KP, Lally PA, Langham MR, et al Congenital Diaphragmatic Hernia Study Group. Surfactant does not improve survival rate in preterm infants with congenital diaphragmatic hernia. J Pediatr Surg. 2004; 39(6): 829-833
43. Wright LL, Horbar JD, Gunkel H, et al. Evidence from multicenter networks on the current use and effectiveness of antenatal corticosteroids in low birth weight infants. Am J Obstet Gynecol. 1995;173(1): 263-269
44. Chien LY, Ohlsson A, Seshia MM, Boulton J, Sankaran K, Lee SK; Canadian Neonatal Network. Variations in antenatal corticosteroid therapy: a persistent problem despite 30 years of evidence. Obstet Gynecol. 2002;99(3): 401-408
45. Horbar JD, Badger GJ, Carpenter JH, et al Members of the Vermont Oxford Network. Trends in mortality and morbidity for very low birth weight infants, 1991-1999. Pediatrics. 2002;110(1 pt 1): 143-151
46. St John EB, Carlo WA. Respiratory distress syndrome in VLBW infants: changes in management and outcomes observed by the NICHD Neonatal Research Network. Semin Perinatol. 2003;27(4): 288-292
47. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;(3): CD004454
48. Gortner L, Wauer RR, Hammer H, et al. Early versus late surfactant treatment in preterm infants of 27 to 32 weeks' gestational age: a multicenter controlled clinical trial. Pediatrics. 1998;102(5): 1153-1160
49. Carlo WA, McDonald SA, Fanaroff AA, et al Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation. JAMA. 2011;306(21): 2348-2358
50. Jobe AH, Mitchell BR, Gunkel JH. Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants. Am J Obstet Gynecol. 1993;168(2): 508-513
51. Kari MA, Hallman M, Eronen M, et al. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study. Pediatrics. 1994;93(5): 730-736
52. White A, Marcucci G, Andrews E, Edwards K, Long W; The American Exosurf Neonatal Study Group I and The Canadian Exosurf Neonatal Study Group. Antenatal steroids and neonatal outcomes in controlled clinical trials of surfactant replacement. Am J Obstet Gynecol. 1995;173(1): 286-290
53. Seidner S, Pettenazzo A, Ikegami M, Jobe A. Corticosteroid potentiation of surfactant dose response in preterm rabbits. J Appl Physiol (1985). 1988;64(6): 2366-2371
54. Ikegami M, Jobe AH, Seidner S, Yamada T. Gestational effects of corticosteroids and surfactant in ventilated rabbits. Pediatr Res. 1989;25(1): 32-37
55. Gladstone IM, Mercurio MR, Devenny SG, Jacobs HC. Antenatal steroids, postnatal surfactant, and pulmonary function in premature rabbits. J Appl Physiol (1985). 1989;67(4): 1377-1382
56. National Institutes of Health. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consens Statement. 1994;12(2): 1-24
57. Carlo W, Polin RA; American Academy of Pediatrics, Committee on Fetus and Newborn. Respiratory support in preterm infants at birth. Pediatrics. In press
58. US Preventive Services Task Force. Grade definition recommendations after 2007. Available at: www.uspreventiveservicestaskforce.org/uspstf/grades.htm. Accessed June 7, 2013